UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 18, 2026

 

Vivid Seats Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other 

jurisdiction of incorporation)

001-40926

(Commission File Number)

86-3355184

(IRS Employer

Identification No.)

     

24 East Washington Street, Suite 900

Chicago, Illinois

(Address of principal executive offices)

60602

(Zip Code)

       

Registrant’s telephone number, including area code: (312) 291-9966

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: 

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A common stock, par value $0.0001 per share   SEAT   The Nasdaq Stock Market LLC
Warrants to purchase Class A common stock   SEATW   The Nasdaq Stock Market LLC*

 

* On October 16, 2026, The Nasdaq Stock Market LLC filed a Form 25 with the Securities and Exchange Commission (the “SEC”) to (i) delist these warrants from the Nasdaq Global Select Market, which delisting became effective on October 26, 2026, and (ii) remove these warrants from registration under Section 12(b) of the Securities Exchange Act of 1934, which deregistration will become effective 90 days, or such shorter period as the SEC may determine, after such filing.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 1.01 Entry into a Material Definitive Agreement

 

On November 19, 2026, Vivid Seats Inc. (the “Company”), Hoya Intermediate, LLC (“Holdings”), Hoya Midco, LLC (the “Borrower”), and certain other subsidiaries of the Company (collectively, the “Company Parties”) entered into a Transaction Support Agreement (together with the exhibits and schedules thereto, including the term sheet attached as Exhibit A thereto, the “TSA”) with (i) certain lenders (the “Consenting Lenders”) holding a substantial majority of the aggregate outstanding principal amount of the term loans (the “Existing Term Loans”) under the First Lien Credit Agreement, dated June 30, 2017 (as amended, restated, supplemented, or otherwise modified from time to time, the “Existing Term Loan Credit Agreement”), among Holdings, the Borrower, the lenders party thereto, and Wilmington Savings Fund Society, FSB (as successor-in-interest to Barclays Bank PLC), as administrative agent and collateral agent, and (ii) Jefferies Capital Services, LLC, as fronting lender (the “Fronting Lender”) for the New First Out Term Loans (as defined below).

 

The TSA sets forth the terms on which the parties have agreed to support and implement a comprehensive recapitalization of the Company’s capital structure (collectively, the “Transactions”). The Transactions include, among others:

 

• Term Loan Exchange. Each Consenting Lender will exchange its Existing Term Loans for (i) $2,944.75 in aggregate principal amount of new first lien, second out term loans (the “Exchanged Second Out Term Loans”) for each $10,000.00 of principal amount of Existing Term Loans held by such Consenting Lender immediately prior to the closing date of the Transactions (the “Closing Date”) and (ii) its pro rata portion of newly issued shares of the Company’s Class A common stock (the “New Common Equity”) representing, in the aggregate, 80.0% of the Company’s Class A common stock immediately following consummation of the Transactions (the “Term Loan Exchange”). No Consenting Lender will hold more than 19.99% of the Company’s Class A common stock immediately following consummation of the Transactions. Existing holders of the Company’s Class A common stock will retain, in the aggregate, 20.0% of the Company’s Class A common stock immediately following consummation of the Transactions.

 

• New Money Financing. The Borrower will receive $66.0 million of new first lien, first out term loans (inclusive of $6.0 million of fees paid-in-kind) (the “New First Out Term Loans”), which will be offered on a pro rata basis to holders of Existing Term Loans that become Consenting Lenders on or prior to the date that is seven days after the TSA is posted to holders of Existing Term Loans (or such later date as may be agreed by the Company and certain of the Backstop Parties (as defined below)). The New First Out Term Loans will be initially funded by the Fronting Lender and have been fully backstopped, severally and not jointly, by certain Consenting Lenders (the “Backstop Parties”).

 

• Other Closing Terms. The Transactions also contemplate, among other things, (i) the entry into a new credit agreement governing the New First Out Term Loans and the Exchanged Second Out Term Loans, (ii) an amendment to the Existing Term Loan Credit Agreement (the “Closing Amendment”), (iii) the repayment of the Company Parties’ existing revolving credit facility and intercompany senior secured credit facility, (iv) the reconstitution of the Company’s board of directors, (v) the adoption of a management incentive plan, (vi) the entry into a registration rights agreement for the New Common Equity, and (vii) customary mutual releases, in each case on terms to be set forth in definitive documentation entered into on or prior to the Closing Date.

 

Under the TSA, the Company Parties have agreed, among other things, to support and take all commercially reasonable actions necessary to facilitate the implementation and consummation of the Transactions, to negotiate in good faith and execute the definitive documentation for the Transactions, to not solicit or pursue any alternative transaction (subject to the right of the governing body of each Company Party to take actions consistent with its fiduciary duties), and, between the date of the TSA and the Closing Date, to comply with customary interim operating covenants. 

 

Under the TSA, each Consenting Lender has agreed, severally and not jointly, among other things, to support and take all commercially reasonable actions to facilitate the implementation and consummation of the Transactions, to provide all consents required for the Transactions, including the Closing Amendment, to not object to or impede the Transactions or support any alternative restructuring of the Existing Term Loans, and to not transfer its Existing Term Loans except to a transferee that is or agrees to become bound by the TSA.

 

The consummation of the Transactions is subject to customary conditions, including participation by holders of at least 99% of the Existing Term Loans, subject to reduction or waiver if agreed by the Company and certain of the Consenting Lenders (the “Minimum Participation Condition”), the execution of definitive documentation, and the payment of fees. The TSA may be terminated by the Company or the required Consenting Lenders upon the occurrence of certain specified events, including uncured breaches, failure to meet specified milestones, and the exercise of the fiduciary out described above. The TSA will terminate automatically if the Closing Date has not occurred by January 31, 2027 (extendable in specific circumstances to March 31, 2027).

 

The TSA contains customary representations, warranties, and covenants of the parties, which were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties, and may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures. Investors should not rely on them as characterizations of the actual state of facts. There can be no assurance that the Transactions will be consummated on the terms described herein or at all.

 

The foregoing description of the TSA and the Transactions does not purport to be complete and is qualified in its entirety by reference to the full text of the TSA, including the term sheet attached as Exhibit A thereto, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Item 3.02 Unregistered Sales of Equity Securities

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. Upon consummation of the Term Loan Exchange, the Company will issue the New Common Equity (approximately 45.8 million shares of Class A common stock) to the Consenting Lenders in exchange for a portion of Existing Term Loans. Such issuance will be made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On November 18, 2026, the Company entered into retention agreements with certain key employees, including each of the Company’s named executive officers (“NEOs”). The retention agreements provide for retention payments to Lawrence Fey, Joseph Thomas, Stefano Langenbacher, and Edward Pickus in the aggregate amount of $771,000, $771,000, $771,000, and $578,000, respectively. Fifty percent of each retention payment is payable immediately, and the remaining fifty percent is payable on November 18, 2027.

 

If an NEO’s employment is terminated prior to November 18, 2027 by the Company for Cause (as defined in the NEO’s employment agreement) or by the NEO without Good Reason (as defined in the NEO’s employment agreement), then the NEO will be required to repay a pro rata, after-tax portion of the first installment of the retention payment and will forfeit the right to the second installment. If an NEO’s employment is terminated for any other reason prior to November 18, 2027, the repayment obligation with respect to the first installment of the retention payment will lapse, but the NEO will not be entitled to receive the second installment. If a Change in Control (as defined in the Company’s 2021 Incentive Award Plan, as amended) occurs prior to November 18, 2027, the repayment obligation with respect to the first installment of the retention payment will lapse and the second installment will become immediately payable. 

 

Item 7.01 Regulation FD Disclosure

 

On November 19, 2026, the Company issued a press release announcing its entry into the TSA. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

In connection with its discussions regarding the Transactions, the Company entered into confidentiality agreements with certain holders of Existing Term Loans pursuant to which it agreed to publicly disclose certain information provided to such holders (the “Cleansing Material”) upon the occurrence of certain events. The Cleansing Material is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The Cleansing Material was prepared as of earlier dates using then-available information solely to facilitate such discussions and speaks only as of such dates. The Cleansing Material was not prepared with a view toward public disclosure and should not be relied upon to make an investment decision with respect to the Company. The Cleansing Material should not be regarded or relied upon as an indication that the Company or any third party considers the Cleansing Material to be a reliable prediction of future events. The Cleansing Material includes certain values that were prepared for illustrative purposes only and are not the result of, and do not necessarily represent, actual valuations, estimates, forecasts, or projections of the Company or any third party and should not be relied upon as such. Neither the Company nor any third party has made or makes any representation to any person regarding the accuracy of the Cleansing Material or undertakes any obligation to publicly update or revise the Cleansing Material to reflect circumstances existing after the date on which it was prepared or conveyed or to reflect the occurrence of future events, even in the event that any or all of the assumptions underlying the Cleansing Material are shown to be incorrect.

 

The information set forth under this Item 7.01, including Exhibits 99.1 and 99.2 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Forward-Looking Statements

 

This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act regarding future events and trends and the future results of the Company and its subsidiaries. Words such as “anticipate,” “believe,” “can,” “continue,” “could,” “design,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “plan,” “project,” “propose,” “seek,” “should,” “target,” “will” and “would,” as well as similar expressions that predict or indicate future events and trends or do not relate to historical matters, are intended to identify such forward-looking statements. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts, and projections about future events and financial trends that it believes may affect its business, financial condition, and results of operations. While the Company believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and the Company’s statements should not be read to indicate that it has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. Forward-looking statements are not guarantees of future performance, conditions, or results, and are subject to risks, uncertainties, and assumptions that can be difficult to predict and/or are outside of the Company’s control. Therefore, actual results may differ materially from those contemplated by any forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to: the ability of the parties to consummate the Transactions on the terms or timeline proposed, or at all, including the satisfaction of the Minimum Participation Condition and other closing conditions; the possibility that the TSA is terminated prior to consummation of the Transactions; and other factors discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as in the Company’s press releases and other filings with the Securities and Exchange Commission (the “SEC”). You should not place undue reliance on forward-looking statements, which speak only as of the date of this report (or, in the case of statements incorporated by reference herein, as of the date of the incorporated statement). Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements contained in this report, whether as a result of new information, future events, or otherwise.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description
10.1*   Transaction Support Agreement, dated as of November 19, 2026, by and among Vivid Seats Inc., the other Company Parties party thereto, the Consenting Lenders party thereto, and Jefferies Capital Services, LLC, as Fronting Lender
99.1   Press release issued by Vivid Seats Inc., dated November 19, 2026
99.2   Cleansing Material
104   Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

*Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K, and certain identified information has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish a copy of any omitted schedule or exhibit to the SEC upon request. 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

  Vivid Seats Inc.
   
Date: November 19, 2026 By: /s/ Joseph Thomas
    Joseph Thomas
    Chief Financial Officer